Effect of cupping and nutrition correction on clinical signs and blood factors of men with stable angina resistant to treatment

Effect of cupping and nutritional correction on clinical signs and blood factors of male patients with persistent chronic angina resistant to treatment

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171004036564N1

Enrollment

Registered

2018-04-09

Start date

2018-02-20

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sustained cardiac angina resistant to treatment. Unstable angina

Interventions

Intervention 1: Control group: Complete Seattle's Angina Inventory and Paraclinical Tests. Intervention 2: Intervention group: Nutrition correction. Intervention 3: Intervention group: Cupping between

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. ??????? ??? 1. Patients with minimal CAD normal coronary artery had incomplete response to drug therapy. (X syndrome) 3. CAD patients who were not suitable for CABG (Coronary Artery Bypass Grafting) and PTCA (Percutaneous Transluminal Coronary Angioplasty). The slow flow syndrome or (Y syndrome) 4. Patients with Microvascular Angina (angina caused by tiny cardiac arrhythmias) 5. Patients with visible venous PTCA patients were not involved in revascularization. 6. CABG patients with visible vascular involvement were not involved in revascularization.

Exclusion criteria

Exclusion criteria: 1. Arrhythmias that lead to functional dysfunction 2. Bleed talent 3. Active thrombophlebitis 4. There is evidence of aneurysm that requires surgery. 5. Patients with significant dysfunction (Severe AL-Severe AS-Severe MS) 6. Change the way the patient continues treatment 7. Anemia (HB less than 10 and HCT less than 30) 8. Very Slim and Very Obese (BMI less than 15 and more than 35)

Design outcomes

Primary

Measure	Time frame
Improve patient pain. Timepoint: The beginning of the study (before the intervention) and 30 days after the intervention. Method of measurement: Seattle's Angina Inventory Complex and Paraclinical Tests.;Changing blood factors. Timepoint: The beginning of the study (before the intervention) and 30 days after the intervention. Method of measurement: Paraclinical tests.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Abazari

Mashhad University of Medical Sciences

ABAZARIM931@MUMS.AC.IR+98 51 3854 3031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026